PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 558.00
Bid: 560.00
Ask: 588.00
Change: -2.00 (-0.36%)
Spread: 28.00 (5.00%)
Open: 558.00
High: 558.00
Low: 558.00
Prev. Close: 560.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

23 Feb 2022 07:00

RNS Number : 4740C
Gooch & Housego PLC
23 February 2022
 

 

For immediate release

23 February 2022

 

Gooch & Housego PLC

("G&H" or the "Company")

 

AGM Trading Update

 

"Strong and improving overall demand"

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, will hold its Annual General Meeting at 11.00am today at the Company's headquarters in Ilminster, Somerset.

 

During the first four months of the financial year, we have seen strong and improving levels of overall demand and the Group has a record order book across its principal areas of business, industrial lasers, telecoms, A&D and life sciences. There continues to be high demand for industrial lasers, in particular for those used in semiconductor manufacturing, where a combination of high market growth and our new products winning market share has led to substantial growth. Hi-reliability fibre coupler demand remains robust for undersea cables and increasingly for constellation space satellites. Medical lasers continue to benefit from the return of elective surgery and demand for our medical diagnostics products remains high.

 

As at 31 January 2022, our order book stood at a record £110.5 million (31 January 2021: £95.0 million), an increase of 16.3% compared with the same time last year.

 

Pandemic- related factors have restrained trade during the period, these include recruitment, self isolation and supply chain challenges. Mitigating actions are in place. As a result, we expect trading to have a slightly higher second half weighting than anticipated, but the full year outcome to remain unchanged.

 

G&H has continued to invest in our increasingly productive R&D group during the period. We have focused on delivering further innovation through collaborations with the leading companies in their sector.

 

The Company remains in a strong financial position with a robust balance sheet and low levels of net debt.

 

G&H remains committed to the long term goals of further diversification into A&D and life sciences and moving up the value chain. We intend to vigorously pursue these policies through internal investment and where appropriate, acquisitions.

 

 

Mark Webster, Chief Executive Officer of Gooch & Housego, commented:

 

"During the first four months of the financial year we have seen strong and improving levels of overall demand and a record order book across all our principal areas of business. Trading during this period has been constrained by pandemic related factors in some parts of our business, but our outlook for the full year is unchanged.

 

"Fundamental demand for our photonic technologies and system capabilities is strong and improving and we remain confident in the short and long term growth potential for G&H in our target sectors."

 

 

 

A slide deck to accompany the AGM can be viewed at the investor section of the Company's website, https://gandh.com/investors/

 

 

 

 

 

 

 

For further information contact: -

 

Mark Webster/Chris Jewell

Gooch & Housego PLC

01460 256440

Mark Court/Sophie Wills

 

Buchanan

020 7466 5000

Chris Baird/ David Anderson

 

 

 

Investec Bank plc

020 7597 5970

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA, Europe and China. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGCPUPPGQP
Date   Source Headline
21st Feb 20192:58 pmRNSDirector Share Purchase
20th Feb 20191:07 pmRNSResult of AGM
20th Feb 20197:00 amRNSAGM Trading Update
9th Jan 201910:17 amRNSGrant of LTIP Awards
9th Jan 20197:00 amRNSSite Visit to ITL Life Science Business
28th Dec 201811:14 amRNSBlock Listing Six Monthly Return
28th Dec 201811:13 amRNSIssue of Equity and Total Voting Rights
28th Dec 201811:12 amRNSBlock Listing Application
11th Dec 20184:44 pmRNSAdditional Listing
11th Dec 20187:00 amRNSPosting of Annual Report and AGM Notice
5th Dec 201811:30 amRNSDirector/PDMR Shareholding
5th Dec 201811:28 amRNSDirector/PDMR Shareholding
27th Nov 201811:36 amRNSDirector/PDMR Shareholding
27th Nov 20187:00 amRNSCFO Succession
27th Nov 20187:00 amRNSPreliminary Results
30th Oct 201811:06 amRNSHolding(s) in Company
29th Oct 201811:08 amRNSHolding(s) in Company
25th Oct 20184:40 pmRNSHolding(s) in Company
25th Oct 20187:00 amRNSNotification of Preliminary Results
23rd Oct 201810:23 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSFull Year Trading Update
26th Sep 20189:00 amRNSHolding(s) in Company
6th Sep 20187:00 amRNSAerospace and Defence Acquisition
8th Aug 20187:00 amRNSLife Sciences Acquisition
12th Jul 20189:26 amRNSHolding(s) in Company
13th Jun 201810:08 amRNSHolding(s) in Company
6th Jun 20182:02 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSInterim Results
3rd May 20187:00 amRNSNotification of Half Year Results
6th Apr 20187:00 amRNSHalf Year Trading Update
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Mar 20188:25 amRNSHolding(s) in Company
21st Feb 20185:20 pmRNSResult of AGM
21st Feb 20187:00 amRNSAGM Trading Update
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
18th Jan 20181:35 pmRNSGrant of LTIP Awards
22nd Dec 20179:13 amRNSBlock Listing Application
22nd Dec 20177:00 amRNSAppointment of Non-Executive Chairman
15th Dec 20177:00 amRNSPosting of Annual Report and AGM Notice
28th Nov 20177:00 amRNSPreliminary Results
23rd Oct 20177:00 amRNSNotification of Full Year Results
4th Oct 20177:00 amRNSFull Year Trading Update
3rd Oct 20174:36 pmRNSHolding(s) in Company
3rd Oct 20174:31 pmRNSHolding(s) in Company
25th Aug 20174:33 pmRNSHolding(s) in Company
16th Aug 20173:54 pmRNSHolding(s) in Company
6th Jun 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.